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ABSTRACT
MATURATION OF HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED ENGINEERED
CARDIAC TISSUES USING CHIEF TRANSFECTION AND CHRONIC OPTICAL PACING
Marc M. Dwenger
May 25, 2017

The immaturity of engineered cardiac tissues (ECTs) limits their ability to
regenerate damaged myocardium and to serve as in vitro disease models and surrogates
for drug toxicity testing. Several chronic biomimetic conditioning protocols, including
mechanical stretch, perfusion, and electrical stimulation promote ECT maturation but
have significant technical limitations. Non-contacting chronic light stimulation using
heterologously expressed light-sensitive ChIEF ion channels, termed optogenetics, may
be an advantageous alternative to chronic electrical stimulation. As a proof of principle,
we transfected ECTs using an AAV packaged ChIEF and then verified acute optical pacing
(OP) by patch clamp. We then chronically OP ECTs for 7 days above the intrinsic beat rate.
Chronic OP resulted in improved ECT electrophysiological properties; however, ECT force
generation and histology remained unchanged. Some changes in cardiac relevant gene
expression were noted. This work validates a novel chronic OP paradigm that can be
used to identify strategies for optimal in vitro ECT maturation.
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INTRODUCTION

Heart disease causes many deaths worldwide, and the heart does not fully
regenerate after injury.1,2 When higher vertebrate heart muscle is damaged, the heart is
unable to fully regenerate cardiomyocytes lost to trauma.2 This incomplete regeneration
leads to pump dysfunction and symptoms of clinical heart failure.3 Currently, most
therapies do not directly remedy this loss of cardiac ability.3 To overcome cardiac tissue’s
limited regenerative capacity and restore the heart’s pumping ability, researchers are
developing cell therapy and tissue engineering paradigms.3
Cell therapy involves transplantation of healthy cells into the damaged tissue to
regenerate the injured myocardium.4 The cells regenerate the damaged muscle through
many possible mechanisms: formation of new blood vessels, paracrine mechanisms, and
cell fusion.4 Cell therapy research has utilized many different cell types: embryonic stem
cells, skeletal myoblasts, bone-marrow derived stem cells, adipose-derived mesenchymal
stem cells, induced pluripotent stem cells, and cardiac stems cells.4 These cells have
varying efficiencies to differentiate into cardiac cells ex vivo before implantation, or
undifferentiated stem cells, transplanted into the heart, become cardiac cells in vivo,
regenerating the necrotic tissue.4 Cell therapy clinical trials demonstrate improved
myocardium function following cell delivery.4 However, after cell
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injection, greater than 90 percent of the cells are lost within the first few days,
limiting the restorative ability of cell therapy.4
Tissue engineering strategies could improve the negative outcomes of cell
therapy; instead of isolated cell delivery, scientists combine cells with biomaterials,
before transplantation, that increase cell retention and differentiation. 5 Many different
tissue engineering protocols exist such as, cardiac patches, injectable delivery matrices,
microspheres for cell encapsulation, and engineered cardiac tissues (ECTs).5,6 Cardiac
patches involve implantation of cells attached to a biopolymer scaffold; whereas,
injectable delivery matrices are thermosensitive materials that gel on injection to improve
cell retention.5 Microspheres capture individual cells in self assembling spherical
constructs for the same purpose.
Engineered cardiac tissues involve the formation of a tissue construct by
combination of cells and extracellular matrix.6 In this strategy, used by our lab, a mold
forms a gelatinous mixture of cells, liquid collagen, Matrigel, and growth supplements
into viable cardiac tissue.6,7 Surgeons, then, implant the tissue onto the heart to
regenerate the myocardium.7 Studies demonstrate this approach improves or sustains
cardiac function after implantation onto damaged rat heart muscle.7 ECTs, derived from
human cells, also, improve cardiac function in a rat cardiac MI model.8 However, this
model has many barriers before clinical translation: determination of optimal tissue size,
immune system rejection, obvious demonstration of ECT electrical coupling to the host
heart, limitations on cell availability, and immature phenotype.
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Regarding phenotype, ECTs have many immature characteristics.9 The maturity of
ECTs surpasses 2D culture; however, no ECT method produces a fully mature construct.9
The constructs produce inadequate force, the tissues possess underdeveloped contractile
machinery, and the contractile units also spontaneously beat.9 In contrast, native cardiac
tissue produces much greater force, the mature muscle has an abundance of contractile
proteins, and the cells elongate and align.9 To improve cardiac maturity, researchers use
bioreactors, that mimic the in vivo environment, to promote differentiation. 10 Many
methods replicate these in vivo signals, such as, mechanical stretch, medium perfusion,
and electrical stimulation.9 Nutrient delivery, in tissue engineering, is usually limited to a
tissue area that can be reached by diffusion; perfusion increases nutrient and oxygen
transport, allowing construction of uniform and thick tissue constructs.10 Mechanical
stretch manipulates integrin binding which activates pathways related to hypertrophy:
MAPK/ERK1/2 and PI3K.11 Changes in stiffness manipulate tyrosine kinase activation and
GTPase activity which activates pathways such as Rho/ROCK to differentiate cells. 11
Electrical stimulation promotes differentiation into cardiomyocytes by replicating
endogenous electric fields present during cardiac development.12 These endogenous
electric fields influence cellular behavior, proliferation, and migration.13 Absence of these
endogenous electric fields in development generate severe defects such as malformed
body parts.13 Even though endogenous electric fields are known to generate these effects,
the mechanism behind electrically-induced maturation still requires explanation.14 Using
a neonatal ventricular rat myocyte, NVRM, culture model, this electrical stimulation
mechanism has been profusely studied.15,16,17
3

An initial study, by McDonough and Glembotski, electrically stimulated NVRMs by
direct stimulation with an electric field.13,15 They placed charged electrodes in the cell
media on opposite sides of the cell culture, establishing an electric field between the
cells.15 They showed long term electrical field stimulation of NVRMs induces a
hypertrophic-like response in the cells.15 The cardiomyocytes enlarged, they organized
their myofibrils, and expression levels of MLC-2 (myosin light chain) and ANF (atrial
natriuretic factor) increased in response to electric stimulation. 15 This study, and
following studies by the same group, focused on the mechanism of this electricallyinduced hypertrophic response.15
McDonough and Glembotski used drug treatments which clarified the mechanism
of electrical stimulation.15 Phenylephrine (PE) stimulated phosphatidylinositol (PI)
hydrolysis and caused an increase in ANF; however, electrical stimulation did not
stimulate PI hydrolysis, suggesting electrical stimulation increases ANF through a pathway
independent of protein kinase C.15 Moreover, chelerythrine, a PKC antagonist, did not
inhibit pacing-induced ANF secretion, further supporting the aforementioned
statement.16 McDonough and Glembotski also demonstrated that, unlike with forskolin
stimulation, electrical stimulation did not increase cAMP formation, suggesting an ANF
signal transduction pathway independent of protein kinase A.15 On the contrary,
nifedipine and W7, a calmodulin inhibitor, blocked ANF secretion, suggesting dependence
of the response to electrical stimulation on calcium influx and the calcium-calmodulin
pathway.15
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Based on these results, McDonough and Glembotski suggested a partial
mechanism for electrical stimulation.15 Calcium influx, as a result of an action potential,
induces calcium-induced calcium release from the sarcoplasmic reticulum; the increase
in cytoplasmic calcium activates CaMK, and the activated CaMK phosphorylates CREB
which allows CREB to bind to CRE-like sequences in the 5’ region of the ANF gene,
stimulating the hormone’s transcription.15 McDonough et al. further elucidated the
mechanism for electrical stimulation by demonstrating pacing-induced activation of
MAPK family member, JNK.17 Calcium transients could activate CaMKs that induce JNK
activity.17 Then, JNK phosphorylation of c-jun could precede transcription of ANF.17
The hypertrophic response, observed by McDonough et al., also involves
mitochondrial proliferation and maturation.18 Xia et al. demonstrated electrical
stimulation increases cytochrome oxidase mRNA, cytochrome oxidase enzyme activity,
and number of mitochondria.18 Malonyl-CoA, a metabolic inhibitor of the CPT-1 enzyme,
more effectively inhibited electrically stimulated cells.18 This enhancement of inhibition
suggested a shift from the liver isoform of CPT-1 to the muscle isoform of the enzyme.18
In fact, they showed electrical stimulation also increased expression of the muscle isoform
of the CPT-1 protein.18
The mechanism underlying these cellular changes involves the transcription of
certain genes in the nucleus.19,20 Expression of c-Fos/c-jun/junB, AP-1 proteins, and NRF1 preceded cytochrome c mRNA transcription.19,20 Supplementing this observation,
mutations of the NRF-1 binding site and a possible AP-1 binding site, CRE, on the Cyt C
gene diminished Cyt c transcriptional response to electrical stimulation.19 These results
5

suggested NRF-1 and AP-1 contribute to the initiation of mitochondrial proliferation in
response to electrical stimulation.19 In a later study, NRF-1 and c-jun binding to the Cyt c
promoter was clearly demonstrated, illustrating their direct involvement in electricallyinduced mitochondrial maturation.20 Along with induction of mitochondrial proliferation
and activity, electrical stimulation also influences metabolic genes.21
Xia et al. showed electrical stimulation upregulates the muscle-specific Adss1
gene, a gene encoding a purine metabolism enzyme, and the stimulation represses the
nonmuscle gene, Adss2.21 Furthermore, they demonstrated this upregulation involves the
calcineurin/NFAT pathway.21 Calcineurin dephosphorylates NFAT, allowing NFAT to
translocate to the nucleus to transcribe the Adss1 gene.21 Cyclosporine A, an inhibitor of
calcineurin, inhibited electrical induction of the Adss1 gene, suggesting the involvement
of calcineurin.21 Also, cells containing mutant NFAT binding sites could not enhance
transcription of the Adss1 gene in response to electrical stimulation.21 Also, mutant GATA
sites inhibited pacing-induced Adss1 gene transcription.21 Taken together, these results
suggest electrical pacing activates the calcineurin/NFAT3 and GATA4 pathways. 21
Simultaneously, as electrical stimulation manipulates metabolism, autocrine growth
factor signaling may also play a role in the electrically-induced hypertrophic response.22
Kaye et al. illustrated paced adult ventricular rat cells released more basic
fibroblast growth factor, and electrical stimulation increased protein content and cell
size.22 This electrically-induced hypertrophic response could be inhibited by an anti-FGF
antibody.22 Additionally, unstimulated cells exposed to basic fibroblast growth factor
exhibited a hypertrophic response.22 These results suggest electrically-induced
6

mechanical contractions alter membrane permeability, allowing release of basic
fibroblast growth factor.22 This result reveals the interplay between mechanical
contractions and electrical stimulation during the hypertrophic response resulting from
pacing.22 Cooperative interaction may also exist between electrical stimulation and
reactive oxygen species (ROS) production to induce hypertrophy.14
Electrical stimulation is known to produce ROS, and, although large amounts of
ROS damage cells, small amounts of ROS can activate pathways related to growth and
differentiation.14 Serena et al. electrically stimulated human embryoid bodies (EBs)
derived from human embryonic stem cells; the EBs differentiated into cardiomyocytes
while, also, producing ROS.14 This result suggests ROS production in response to electrical
stimulation may induce cardiomyocyte differentiation.14 Another study, by Chan et al.,
also cited ROS as a second messenger that can activate signaling cascades related to
growth and differentiation.23
Calcium cycling in the cytosol has been highlighted as essential to the growth and
differentiation response; however, calcium may also contribute to electrically-induced
hypertrophy by other means.15,24 Electrical stimulation of human atrial cardiac progenitor
cells induced greater calcium cycling in the nucleus than in the cytosol.24 Therefore,
electrically-induced calcium cycling may cause activation of calcium dependent proteins
and transcription factors involved in differentiation.24 Calcium also influenced alignment
of cardiomyocytes.24 Calcium-free media caused cardiac progenitor cells to align less
parallel to the electric field lines.24 In contrast, calcium-rich media induced parallel
alignment to the electric field lines.24
7

Calcium signaling is complemented by VEGF production in the mechanistic
response to electrical pacing, and this VEGF production can induce angiogenesis in
immature cardiac cells.25 Rackauskas et al., utilizing subthreshold high-frequency
electrical field stimulation on NVRMs, induced secretion and protein expression of
VEGF.25 Furthermore, VEGF secretions into the cell media promoted proliferation of
human coronary artery endothelial cells, promoting angiogenesis.25 This result suggests
electrical stimulation can induce angiogenesis through VEGF production.25
Because electricity induces cardiac maturity, many clinical cell therapy and tissue
engineering research methods apply electrical stimulation paradigms. Skeletal progenitor
cells, used for cell therapy, respond to electrical pacing similarly to cardiac cell types. 26,4
C2C12 muscle cells cultured and electrically stimulated on Ultrafoam collagen sponges
deposited less collagen 1, correlating with less scar formation.26 The electrically
stimulated C2C12 myotubes contracted effectively, and the stimulation improved
ultrastructure such as sarcomere organization.26 Likewise, Pedrotty et. al demonstrated
electrical stimulation induces cell proliferation of skeletal myoblasts on PGA scaffolds, but
the cells failed to differentiate into cardiac cells.27 While these results relate to cells from
a skeletal origin, electrical stimulation can also manipulate differentiation of stem cells,
used in cardiac regeneration, such as mesenchymal and adipose derived stem
cells.4,28,29,30
Electrically stimulated mesenchymal stem cells seeded with carbon nanotubes
elongated, aligned perpendicular to the electric field, and increased expression of cardiac
markers.29 Human adipose derived stem cells, in response to DC electric stimulation
8

elongated and aligned perpendicular to the electric field, possibly, to minimize voltage
across the cell.30 Thrombomodulin, VEGF, and FGF upregulated in response to
stimulation.30 Connexin-43 upregulated after the first two hours of stimulation, but,
subsequently, the junction downregulated after four hours of stimulation. 30 Therefore,
connexin disassembly and alignment simultaneously occur in these cells.30 In a following
study, Pavesi et al. showed similar increased expression of connexin-43 from biphasic
electrical stimulation of mouse adipose-derived stem cells.31 As suggested earlier,
electrical stimulation does not rely upon the absence of a cardiac phenotype; cardiac cells
destined to be a cardiac cell can be further driven towards a mature cardiac phenotype
by electrical stimulation.
NVRMs, electrically stimulated and seeded on ultrafoam collagen sponges, gained
improvements in contractility, expression of cardiac proteins, cardiac differentiation, and
ultrastructural organization.32 Amplitude of contraction, excitation threshold (minimum
voltage at set pacing frequency), and maximum capture rate (highest pacing frequency)
improved in stimulated constructs.32 Electrical stimulation elevated levels of troponin,
creatine kinase-MM, and myosin heavy chain.32 Stimulated constructs displayed mature
H, I, and A bands, and myofibers aligned along electric field lines.32 However, cellular
maturation depended on onset of electrical stimulation: initiation of electrical stimulation
on day 3 improved cellular phenotype better than electrical stimulation initiation on day
1 or 5.32 Electrical stimulation alone does not induce fully developed cardiac constructs;
electrical stimulation of cardiac progenitor cells combined with other differentiation cues
can improve the recapitulation of the native myocardium.9,33
9

Heidi Au et al. electrically stimulated fibroblasts and neonatal rat ventricular
cardiomyocytes on microabraded and non-abraded surfaces to study the combined and
separate effects of these cues.33 Micoabrasions replicated the topographical cues in the
native myocardium that guide orientation and elongation of cells.33 Combinations of
these cues improved alignment and elongation compared with just electrical stimulation
alone.33 Electrical stimulation and microabrasion influenced cell elongation similarly, but
microabrasion had greater influence over cell orientation.33 Cell morphology and the
contractile apparatus improved the most by combination of abrasions and electrical
stimulation compared with electrical stimulation alone.33 Along with topographical cues,
the native heart also contains dense capillary network that minimizes nutrient and oxygen
transport.10
To mimic this situation in vitro, Maidhof et al. simultaneously perfused and
stimulated NVRMs seeded on porous PGS scaffolds.10 Medium perfusion through porous
PGS scaffolds enhanced nutrient transport, and the pores protected cells from
hydrodynamic shear, a morphology-altering force.10 The bioreactor allowed free
contraction of the construct to retain differentiation induced by mechanical stretch. 10
Perfusion and electrical stimulation of porous PGS scaffolds containing NVRMs improved
excitation threshold (ET), maximum capture rate (MCR), and amplitude of contraction
compared to electrical stimulation alone.10 Also, this combination maintained DNA
content, increased creatine kinase expression, and increased troponin content as
compared to electrical stimulation alone.10 As cited previously, mechanical stretch and
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electrical stimulation also combine to improve cardiac maturity. The following study more
explicitly demonstrates this tendency.
Wang et al. studied the effects of mechanical stretch and electrical stimulation of
acellular porcine myocardial scaffolds seeded with mesenchymal stem cells.28 Synergistic
effects of mechanical stretch and electrical stimulation improved recellularization, tissue
remodeling, and cardiac differentation.28 Enhanced properties included improvement of
cell alignment, induction of nonlinear anisotropic behavior, and formation of cell
junctions.28 These constructs expressed myosin heavy chain, alpha actinin, and cardiac
troponin T.28 Interestingly, alignment only occurred in the presence of mechanical
stimulation; whereas, electric fields alone could not reorient the cells.28 Physical stressors
play an important role in cardiac induction, but growth factors can also induce
differentiation.
Park et al. investigated the effects of IGF-1 exposure on electrically stimulated
cardiac constructs.34 Cardiac construct viability, differentiation, and functional properties
benefit from IGF-1 exposure.34 This combination increased connexin-43 expression,
sarcomere development, and 2D projection length, a contractility indicator compared
with electrical stimulation alone.34 Electrical stimulation induced cell alignment along
electric field lines regardless of IGF-1 activity.34 The group surmised a mechanism for
these results; the anti-apoptotic effects and pro-differentiation effects of IGF-1
synergized with electrical stimulation’s induction of contractile protein assembly. 34
Combinations of growth factors and electrical stimulation induce substantial cell
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differentiation; however, interest lies in improvement of electrical stimulation rather than
combination of ES (electrical stimulation) with other protocols.29,35
Nanowires, deposited in the cardiomyocyte cell culture, also, synergistically
improve electrical stimulation.35 Richards et al. electrically stimulated human induced
pluripotent stem cell derived cardiac spheroids containing conductive silicon nanowires.35
The stimulation of the conductive silicon wires reduced spontaneous beating similar to
with electrical stimulation alone, decreasing the risk for arrhythmogenicity complications
after transplantation.35 They suggested reduction of HCN4 mRNA, RNA encoding a
pacemaking channel, caused a decrease in spontaneous beating.35 Silicon wire
stimulation significantly increased expression of connexin-43 and a mechanical junction,
N-cadherin in comparison with electrical stimulation without nanowires.35 High levels of
mechanical junctions may improve cellular integration after transplantation. 35
Stimulated/nanowired spheroids expressed enough sarcomeric proteins to generate
sarcomeric banding; whereas, electrical stimulation alone produced less mature
sarcomeres.35 These spheroids, in comparison with electrical stimulation alone, also,
handled calcium more effectively through increased expression of the ryanodine
receptor.35 Beta-MHC and cardiac troponin increased expression in wired/stimulated
constructs, in comparison to electrical stimulation alone, consistent with in vivo
cardiomyocyte maturation.35 Wired and stimulated spheroids increased expression of
myosin-light chain 2 on the gene and protein level in comparison with electrical
stimulation alone, suggesting a shift towards a ventricular phenotype.35
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In a similar study, Ahadian et al., using dielectrophoresis, aligned carbon
nanotubes in methacryloyl hydrogel scaffolds.36 Electrical stimulation of the scaffolds,
containing mouse derived cardiac EBs, improved cardiac differentiation compared with
electrical stimulation alone.36 Scaffolds with aligned carbon nanotubes, following
stimulation, compared with electrical stimulation alone, increased troponin T expression,
and the excitation upregulated the cardiac genes: Tnnt2, Nkx2-5, and Actc1.36 In contrast
to the previous study, spontaneous beating of the cardiac EBs cultured with carbon
nanotubes increased in response to electrical stimulation compared with electrical
stimulation alone.36 Manipulation of stimulation parameters can also optimize electrical
response rather exogenous addition of conductive materials.
Tandon et al. found electrode length must be twice the electrode spacing for
optimal electrical pacing, and electric field strength must be 8 V/cm or lower to retain
construct viability.37 In a following study, Tandon et al. showed placement of constructs
within a 4mm distance from the midway point between electrodes exposes cells to a
linear electric field.38 Also, carbon electrodes stimulated tissues most effectively.38 These
electrodes retained stimulus, and the electrodes injected and recovered the most charge,
a potential toxicity to cells.38 Also, carbon induced maturation of functional properties,
MCR and ET, most effectively.38 By comparing functional properties of tissues paced with
different stimulation protocols, Tandon et al. identified optimal stimulation parameters
for electric field strength, frequency, and pulse duration: 3 V/cm, 3Hz, 2ms. 38
Another stimulation parameter for optimization of the waveform involves the
phasic nature of the electrical propagation as mentioned earlier.31 Electrical stimulation
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can be either monophasic or biphasic.38 Biphasic electrical stimulation requires less
energy, is more efficacious, and the reduces charge buildup that causes cellular
damage.38,39 Chiu et al. used biphasic electrical stimulation on PEG discs seeded with
embryoid body-derived mouse endothelial cells, NVRM cardiomyocytes, and NVRM
fibroblasts.39 Biphasic stimulation more effectively increased cell density, formation of
contractile organoids, connexin-43 expression, and proliferation of fibroblasts in
comparison with monophasic stimulation.39 Furthermore, biphasic stimulation may have
induced growth factor secretion, leading to fibroblast growth.39 Pietronave et al. used
biphasic stimulation on c-kit/Sca-1-expressing human cardiac progenitor cells (hCPCs).40
Biphasic stimulation, in comparison with monophasic stimulation, more effectively
upregulated transcription factors for cardiac development after three days of stimulation:
MEF2D, GATA4, and Nkx2.5.40 Furthermore, connexin-43, troponin T, and a calcium
channel (Cav2.1) similarly upregulated in response to biphasic stimulation in comparison
with monophasic stimulation.40 Finally, biphasic stimulation, in comparison with
monophasic stimulation, also, increased localization of connexin-43 to the cell
membrane, and stimulated cells tended orient perpendicular to the electric field.40 While
these studies provide a basis for electrical stimulation, most important to the research
presented here is previous work concerning electrical stimulation of ECT constructs.
ECT constructs under electrical stimulation, also, differentiate into more mature
tissues. Lasher et al. chronically stimulated rat ECTs, inducing improved myocyte volume
fraction, alignment, and enhanced connexin-43 distribution.41 Control unstimulated ECTs
possessed sparse connexin-43 connections, indicating the immature electrophysiology in
14

these constructs; whereas, more mature postnatal myocardium expressed higher
connexin-43 proteins.41 The improved connexin-43 distribution shows electrical
stimulation drives maturity to a postnatal phenotype. Excitation threshold and maximum
capture improved in electrically stimulated constructs.41 Hirt et al. electrically stimulated
human induced pluripotent stem cell-derived ECT constructs.42 Stimulated human ECTs
produced higher force, and stimulated ECT orientation and histological maturity
improved compared to unstimulated constructs.42 Moreover, a stimulation protocol that
combined periods of 2Hz and 1.5Hz stimulation improved cell maturity better than a .5Hz
stimulation protocol.42 Nunes et al. constructed and electrically stimulated ECTs by
seeding human stem cell derived cardiomyocytes in collagen gels around a conductive
surgical suture.43 Electrical stimulation of these biowires enhanced ultrastructure,
electrophysiological properties (MCR and ET), and electrically stimulated biowires
possessed increased potassium channel (KCNJ2) mRNA compared to age-matched
embryoid bodies.43 Surprisingly, a ramp-up protocol from 1 Hz to 6 Hz produced the
greatest maturation even though stimulation surpassed physiological frequency.43
Godier-Furnemont et al. subjected NVRM derived circular ECTs to chronic electrical
stimulation, inducing a positive-force frequency relationship in the ECT.44 A positive-force
frequency relationship is a force increase as frequency progresses to higher stimulation
rates.44 The positive-force frequency relationship seems to depend on mature
intracellular calcium stores which allow rapid calcium cycling.44 Correlating with this
underlying mechanism, these ECTs possessed matured T-tubules, SERCA2a protein
expression, and RYR2 protein, providing a basis for the positive force-frequency
15

relationship.44 Also, an enhancement in frequency-dependent acceleration of ECT
relaxation and calcium sensitivity accompanied the positive force-frequency
relationship.44
We tested electrical stimulation on our ECTs, incorporating human induced
pluripotent stem cell derived cardiomyocytes (h-iPSC-CMs), but we have failed to observe
an increase in cardiomyocyte maturity. As an explanation of this result, electrical
stimulation does seem to be somewhat h-iPSC cell line dependent.12 Besides these poor
results, this stimulation paradigm has other hindrances. Electrical stimulation can be
invasive, requiring insertion of electrodes into the ECT.43 During electrical stimulation,
Faradaic reactions occur which release toxic substances into cell media, limiting electrical
pulses to under 1 ms, and electrical stimulation produces pH alterations.45,46,47 Electrical
stimulation also has low spatiotemporal resolution because the excitation is not cellspecific, and the stimulation has no innate negative feedback control.45,48
An alternative, and possibly better, strategy to electrical stimulation is
optogenetics.45 Optogenetics involves heterologous expression and light stimulation of
channelrhodopsin light sensitive ion channels, derived from alga, to produce action
potentials.49 After heterologous expression of channelrhodopsin, absorption of blue light
causes an all-trans retinal chromophore, in the channel, to isomerize to 13-cis retinal.49
This isomerization opens the ion channel, allowing sodium ions into the cell which
produces this action potential.49 Darkness causes the chromophore to assume its natural
trans conformation which, subsequently, closes the channel.49 Boyden et al. first
heterologously expressed channelrhodopsins in mammalian cells, and, since this initial
16

study, many research endeavors in neuroscience and cardiology, use channelrhodopsins
for controlled action potential generation in cells.49,50,51 The light sensitive ion channels
used for interrogation include chimeric and mutant channelrhodopsin variants with
improved properties: higher conductance (ChR2/H134R), improved kinetics (ChETA), and
lower light desensitization (ChIEF).52 Rhodopsin proteins also exist that inhibit action
potential initiation: halorhodopsin, an inward chloride pump, and archaerhodopsin, an
outward proton pump.53
Many advantages exist for this stimulation paradigm in comparison to electrical
stimulation. Because the cell membrane expresses these ion channels, this stimulation
paradigm can occur at a cell-specific level, increasing spatiotemporal resolution for more
precise investigation of electrophysiology.45,48 Introduction of channelrhodopsins
eliminate the need for electrodes; therefore, light stimulation is less invasive.43 Also, toxic
byproduct release is uncommon with channelrhodopsin excitation, and, because the
stimulation directly opens channels with a reversal potential, light stimulation has innate
negative feedback.45 Application of optogenetics to cardiac research is relatively new;
however, the studies, thus far, demonstrate the advantages of this technique.54, 55, 56, 57, 58
Cardiac optogenetic investigation initially started when Bruegmann et al.
produced a channelrhodopsin expressing embryonic mouse stem cell line.46
Cardiomyocytes, differentiated from this stem cell line, contracted in response to blue
light.46 Calcium imaging demonstrated light pulses induced calcium transients in the
cardiomyocytes, and longer light pulses increased release of calcium.46 Light-induced
stimulation generated propagation through a syncytium of cardiomyocytes plated on
17

multielectrode arrays, and point stimulation allowed propagation initiation at different
points in the syncytium.46
Cardiomyocytes can also couple to optically responsive noncardiac cells, and the
cardiomyocytes contract in response to optical excitation of the coupled cells. 51 Jia et al.
transfected human embryonic kidney (HEK) cells with channelrhodopsin.51 Using patch
clamp and calcium imaging, light stimulation elicited action potential currents in the HEK
cells, and these currents propagated to co-cultured neonatal rat cardiomyocytes and
adult canine cardiomyocytes.51 Cabenoxolone, a gap junction uncoupler, eliminated
propagation of these light-induced currents to co-cultured cardiomyocytes, providing
evidence for current initiation from light sensitive HEK cells and propagation of these
currents through gap junctions to the co-cultured cardiomyocytes.51 Propagation
occurred in cell pairs and, also, through two-dimensional layers of cells.51 Action
potentials, calcium transients, wave propagation, and conduction velocities were similar
to electrical stimulation.51 Furthermore, light stimulus caused, not only action potential
propagation, but, also contraction of the cardiomyocytes.51 They showed low irradiance
needed for excitation, indicating the possible energy efficiency of this approach compared
to electrical stimulation.51
Cardiac optogenetics extended to cardiomyocytes derived from human
embryonic stem cells when Abilez et al. transduced human embryonic stem cells with a
channelrhodopsin lentiviral vector; these stem cells, after differentiation into
cardiomyocytes, electrically responded and contracted to blue light stimulation. 49 Abilez
also provided evidence for rhodopsin functionality in h-iPSC-CMs.47 H-iPSC-CMs,
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expressing channelrhodopsin and halorhodopsin, responded to light, increasing or
decreasing contraction rate.47 Along with acute stimulation, Abilez also provided a LED
array for chronical stimulation and subsequent differentiation of optically responsive hiPSC-CMs.59
Optogenetic functionality can also be extended to 3D tissues. Sakar et al.
expressed channelrhodopsin in C2C12 myotubes, and skeletal microtissues formed from
these myotubes contracted in response to optical excitation.60 In a similar study, Chan et
al. generated neonatal rat ECTs seeded with channelrhodopsin-expressing HEK293T
cells.61 These ECTs contracted in response to OP, demonstrating the feasibility of
optogenetics in ECTs constructs.61
Optogenetics could also be used as tool for cardioversion and pacemaking.62 Atrial
fibrillation is often treated with drug therapy or electrical cardioversion despite the
proarrhythmic and painful tissue-damaging effects of these therapies, respectively.54
Bingen et al. showed, by expressing a channelrhodopsin in neonatal rat atrial monolayers,
that reentrant spiral waves, a symptom of atrial fibrillation, can be terminated with
optogenetic excitation.54 Optogenetic stimulation increased functional core size of spiral
waves, resulting in phase singularity drift that caused collisions which terminated the
spiral waves.54 Essentially, this paradigm provides a painless shock-free means of
cardioversion.54 Supplementing this study, Burton et al. demonstrated direction reversal
of spiral wave rotation, further exhibiting the high spatiotemporal resolution of this
optogenetic technique.63
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Drawbacks exist with pacemakers, as well, and these hindrances can be improved
through use of optogenetics. Pacemakers need constant battery replacements, the
electronic components do not replicate the native pacemaker, and pacing leads do not
reach certain anatomical regions.62 The biological nature of an optogenetic pacemaker
could remedy these issues.62 Nussinovitch et al. theorized an implantable optogenetic cell
graft could act as a biological pacemaker.62 Progressing towards this goal, Nussinovitch et
al. coupled optogenetic fibroblasts with human and rat cardiomyocytes.62 Light
stimulation of the fibroblasts generated contraction in the cardiomyocytes, synchronized
non-coupled cardiomyocytes, and activated multiple specific sites in the culture. 62 These
results provide preliminary evidence for efficacy of this optogenetic approach in
conduction abnormality treatment.62 This approach could also potentially treat
tachyarrhythmias as ArchT, an inhibitory rhodopsin, suppressed contractions in the
fibroblast-cardiomyocyte co-cultures.62
Following initial successful in vivo optogenetic experiments by Bruegmann et al.
and Arrenberg et al., Nussinovitch and Gepstein used an adeno-associated viral vector
containing channelrhodopsin to infect rat hearts.46,56,64 Optical excitation of
channelrhodopsin paced the whole heart, and channelrhodopsin activation, at multiple
sites, resynchronized the ventricles.64 Recently, Nyns et al. provided support for a feasible
optogenetic pacemaking and defibrillation therapy.55 The group demonstrated
optogenetic termination of rat ventricular tachyarrhythmias in a Langendorff-apparatus,
possibly through prolongation of action potential duration.55
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In addition, in vivo OP can answer basic science questions concerning the
propagation and termination of arrythmias.65 Zaglia et al. used optogenetics to reveal the
minimum cell number required for ectopic beats, the arrhythmogenic potential of
different heart areas, and the role of different cell types.65 For example, ectopic beats
only required OP of 1,000 to 2,000 cardiomyocytes, but only 100 Purkinje fibers, under
OP, generated ectopic beats, suggesting a higher arrhythmogenic potential of conducting
cardiomyocytes.65
Optogenetics is also conducive to high-throughput drug testing unlike traditional
electrophysiological approaches.57 An all-optical approach, using voltage-sensitive and
calcium-sensitive fluorescent dyes as readouts in combination with optogenetic
actuation, does not require tedious contact with the cell, and light stimulation can test
many cultures in parallel, further contributing to rapid readout times. 57 Rapid readout
times result in more efficient identification of toxic drug candidates.57 In this regard,
Klimas et al. developed OptoDyCE, an all-optical automated high-throughput drug testing
system.57 This system tests drugs by combining optogenetic actuation and optical sensing
of readouts such as voltage.57 OptoDyCE is amenable to 96-well formats and 384-well
formats, allowing many parallel experiments.57 In a similar study, Dempsey et al.
developed Cardiac Optopatch: a high-throughput drug testing system combining
simultaneous OP, voltage imaging, and calcium imaging.58 Optopatch efficiently detects
drug-induced effects on action potential morphology and calcium transients which could
improve drug testing protocols based on hERG blockade.58
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To supplement these studies and extend optogenetics to the field of chronic ECT
stimulation, in my thesis related study, we expressed ChIEF in h-iPSC-CM ECTs using an
adeno-associated virus packaged with this rhodopsin. We investigated the ion channel’s
functionality in the constructs by patch clamp. After chronic stimulation for 7 days, we
assessed the ECTs for maturity, using force testing, histology, RT-qPCR and alignment
testing.
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MATERIALS AND METHODS

Differentiation of Human iPS cells into Cardiac Cells
We used two h-iPS cell lines: 201B6 and 863B3. Kyoto University shipped these
cell lines to University of Louisville as a component of a Collaborative Research
Agreement. Retroviral introduction of Oct3/4, Sox2, Klf4, c-Myc generated 201B6.
Introduction of non-integrating episomal plasmids encoding L-Myc, LIN28, Glis1, Sox2,
Klf4, and Oct3/4 generated 863B3. We cultured h-iPSC cell lines on matrigel (growth
factor reduced, 1:60 dilution; BD Biosciences, San Jose, CA) in human basic fibroblast
growth factor (hbFGF; WAKO, Osaka, Japan), 4 ng/ml, augmented mouse embryonic
fibroblast conditioned medium (MEF-CM). We subcultured small clusters (every 4-6 days)
in CTK solution [0.25% Trypsin, 1mmol/L CaCl2 in phosphate buffered saline (PBS), 20%
knockout serum replacement (KSR), and 0.1% collagenase IV]. To induce cardiac
differentiation, we removed cells from culture plates by incubating the cells in Versene
(0.48 mmol/L EDTA solution; Life Technologies, Carlsbad, CA) for 3 to 7 minutes. At a
density of 1,000 cells/mm2, we plated these cells onto matrigel-coated plates in MEF-CM
augmented with 4 ng/ml hbFGF for a few days before differentiation. A day before
induction, we covered the cells with matrigel (1:60 dilution). We differentiated cells into
cardiac cells using the following steps. On differentiation day 0, we replaced MEF-CM with
RPMI+B27 medium (RPMI1640; Life Technologies 2 mmol/L L-glutamine;
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LifeTechnologies, 1x B27 supplement without insulin: Life Technologies)
augmented with Activin A (R&D, Minneapolis, MN) and Wnt3a (R&D) both at a
concentration of 100 ng/ml for one day. The following day, differentiation day 1, for 2 or
4 days with no media change, we exposed the cells to 10 ng/ml human bone
morphogenetic protein 4 (BMP4; R&D) and 10 ng/ml hbFGF. We replaced the culture
medium on day 5 with RPMI+B27 augmented with 50 ng/ml of VEGF165 (Miltenyi, Bergisch
Gladbach, Germany) to differentiate cells into a mixture of cardiomyocytes and
endothelial cells (CM+EC protocol). We changed the medium every 48 hours. On day 11
to day 13 of induction, the cells began to beat. In accordance with the cardiomyocyte and
mural cell induction protocol (CM+MC), we cultured the cells in RPMI+B27 augmented
with insulin (Life Technologies) and 100 ng/ml of Dkk1 (R&D) starting on day 5. We
cultured the cells in this medium until day 7 while changing the media every other day.
To generate only mural cells (MC protocol), we replaced the media with RPMI+10% FBS
medium [RPMI1640, 2 mmol/L L-glutamine, 10% fetal bovine serum (FBS)] on
differentiation day 3. We changed this culture media every day, as well.
Lineage Analysis
On day 15 of differentiation, we added Accumax (Innovative Cell Technologies,
San Diego, CA) to dissociate cells from cell culture plates. We stained the cells with the
following surface markers: anti-VCAM1 conjugated with allophyco-cyanin (APC,
BioLegend), anti-PDGFRβ conjugated with phycoerythrin (PE, BD, Franklin Lakes), anti-VEcadherin conjugated with fluorescein isothiocyanate (FITC, BD), and anti-TRA-1-60
conjugated with FITC (BD). We stained the cells with LIVE/DEAD Aqua dead cell staining
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kit (Invitrogen). Finally, we stained the cells with anti-cardiac isoform of Troponin T (cTnT,
Thermo-Fisher) tagged with Alexa-488 (Invitrogen). We stained the cells in PBS with 5%
FBS for cell surface markers. We stained cells fixed with 4% paraformaldehyde (PFA) for
intracellular proteins. We analyzed the stained cells with a BD LSRII Flow Cytometer and
DIVA software (BD).
Engineering of ChIEF-Expressing Engineered Cardiac Tissue
After lineage analysis, we used a varying distribution of differentiated cells
(cardiomyocytes, endothelial cells, and mural cells) for engineering of control and ChIEFexpressing ECTs. We combined three million cells with matrix factors to construct one
linear tissue. First, we suspended the three million cells in 83 ul of culture medium
(Modified Dulbecco’s Essential Medium, Invitrogen) containing 20% FBS (Invitrogen) in a
15ml tube. Then, we neutralized acid-soluble rat-tail collagen type-1 solution (Sigma)
(pH=3 in HCl) with alkali buffer (0.2M NaHCO3, 0.2M HEPES, 0.1 M NaOH) on ice in a
separate PCR tube. We added Matrigel to the collagen solution at 15% of the total
volume. We mixed the cell suspension and matrix solution at a collagen concentration of
0.67 mg/ml. The final volume of the cell/matrix mixture is approximately 200ul. We
transfected the cell/matrix mixture with an AAV1/2-CAG-oChIEF-tdTomato virus (a gift
from the Guido lab, originally produced by VectorBioLabs, Malvern, PA). We used the
virus (2x1012 VG/ml) at an MOI of 500 (1.5x109 viral particles per 3 million cells in each
ECT). We poured the 200ul of the cell/virus/matrix mixture into a vacuum-suctioned
trough (20mm length x 2mm width) composed of a Flexcell Tissue Train collagen type-1
coated silicone membrane (TissueTrain; Flexcell International, Hillsborough, FL). We
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controlled vacuum-suction with a FX-5000TT system (Flexcell International). The vacuumsuctioned trough had anchors on either end to hold and shape the tissue into a linear
format. The mixture was vacuum suctioned in an incubator for 120 min (37°C, 5% CO2).
After gel compaction induced by vacuum suction, we added pre-culture medium [PM;
alpha minimum essential medium (αMEM; Life Technologies) augmented with 10% FBS,
100 U/ml Penicillin-Streptomyocin (Life Technologies), and 5×10-5 M 2-mercaptoethanol
(Sigma)]. We maintained ECTs at 37C and 5% CO2 to culture day 14 (D14), changing
media every other day. We additionally performed prolonged culture to D28 for a set of
non-transfected, non-paced ECTs.
Chronic Light Stimulation
We clearly defined the chronic light stimulation protocol in Figure 1B. Between D7
and D14 of ECT culture, we performed chronic optical pacing (C-OP) of transfected ECTs
with a custom-built LED system. The system consisted of 470-nm wavelength blue LEDs
(Luxeon, Alberta, Canada) driven by BuckPuck DC LED drivers (LEDsupply, Randolph, VT).
We mounted the LEDs on a high-alpha heat sink (Luxeon) for thermal management. We
controlled the pulse width and frequency of the LEDs using an Arduino Uno
microcontroller (Italy). We programmed the Arduino with free Arduino IDE software.
Using this LED system, we adjusted the pacing rate every day to at least 0.5 Hz below the
maximum capture rate. We kept the pulse width at 5 ms. We assessed maximum capture
rate by observing pacing through a microscope camera (model MU1000, AmScope, Irvine,
CA). Maximum capture rate was the highest pacing frequency before initiation of
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asynchronous contractions. We used custom video tracking software if assessment of
maximum capture rate was difficult.
Force Testing
Before force measurement, we removed the linear tissue from the FlexCell culture
plate. We placed the tissue in cold Tyrode’s solution (25°C) in a perfusion chamber
containing 95% O2 and 5% CO2. The Tyrode’s solution was composed of (in mmol/L) 119.8
NaCl, 5.4 KCl, 2.5 CaCl2, 1.05 MgCl2, 22.6 NaHCO3, 0.42 NaH2PO4, 0.05 Na2EDTA, 0.28
ascorbic acid, 5.0 glucose, and 30 2,3-butanedione monoxime (BDM). Using 10-0 suture,
we tied the tissue to a stainless steel bar, in the perfusion chamber, connected to a force
transducer (model 403A; Aurora Scientific, Ontario, Canada). We attached the opposite
end to a stainless steel bar, high-speed length controller (model 322C, Aurora Scientific),
connected to a micromanipulator. We, then, filled the perfusion chamber with warmed
Tyrodes’s solution (37°, 2ml volume) containing no BDM. We preconditioned the
construct for 20 minutes at slack length with no stimulation. Using the micromanipulator,
we moved the length controller to stretch the construct to maximum length (Lmax). At
maximum length, we performed force measurements with a series of optical and
electrical stimulation protocols. We optically stimulated the transfected tissue at 5ms
pulse widths with an Arduino powered blue LED, and we electrically stimulated the
constructs with electrodes in the perfusion chamber. During both optical and electrical
stimulation protocols, we increased pacing frequency by 0.5 Hz from a 2 Hz baseline until
we obtained maximum capture rate. We measured excitation threshold by pacing the
construct at 2 Hz and decreasing the voltage until the construct could no longer capture.
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Using custom FFT analysis software on the force traces from optical and electrical
stimulation protocols, we retrieved active stress (mN/mm2), intrinsic beat rate, maximum
capture rate (Hz), normalized force-frequency, beat variation, relaxation time to 50%
(RT50), and systolic energy at 3 Hz.
Patch Clamp
Patch clamp recordings were performed similarly to previously described
protocols.66 At D14, we removed the ECT from the FlexCell culture plate, and placed the
tissue in a recording chamber continuously perfused with the same BDM-infused Tyrode’s
solution (2.5ml/min, 95% O2/5% CO2) used in force testing. We maintained the solution
at 37°C. For differential interference contrast imaging of ChIEF expression, we used a 10x
or 60x water-immersion objective (Olympus) and CCD camera on an upright microscope
(Olympus BX51WI) with a filter (Chroma 49005) for tdTomato (tdT) expression. Then, we
pulled borosilicate glass capillaries using a vertical puller (Narishige), and they were filled
with the following solution: 117mM K-gluconate, 13.0mM KCl, 1MgCl2, 0.07 CaCl2, 0.1
EGTA, 10 HEPES, 2 Na-ATP, and 0.4 Na-GTP. We maintained internal solution osmolality
and internal solution pH at 290 mOsm and 7.3, respectively. We patched the filled
borosilicate capillary onto a single cell in the ECT. We used a Multiclamp 700B amplifier
(Molecular Devices) for whole cell recordings.
Light from a blue light emitting diode (Prizmatix UHP 460) reflected into the 4x or
60x objective. This light optically activated the ChIEF-expressing ECT. The LED light for the
4x and the 60x objective was 2.2 or .45mm, respectively. We controlled pulse duration
and frequency through software. A Multiclamp 700B amplifier (Molecular Devices)
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recorded from the single cell during optical activation of the whole ECT. Filtered data was
analyzed with pClamp 10 software (Molecular Devices).
Histology & Alignment
After ECT fixation in 4% PFA for 30 minutes at room temperature, we rinsed the
ECTs in 1xPBS. We then cut the ECTs in half along the short-axis cross section. We washed
the halves in 1% Triton-X-100/PBS for 1 hour at RT. We blocked with 1% Triton-X-100/PBS
+ 10% FBS for 1 hour at RT. We incubated the tissues with a primary antibody for cTnT
(mouse, Ms-295, Thermo Fisher Scientific, Cambridge, US) at a ratio of 1:400 in 1% TritonX-100/PBS + 10% FBS + 0.02% sodium azide overnight at 4°C. After this overnight
incubation, we washed with 1% Triton X-100/PBS+10% FBS for 1 hour and 1% Triton X100/PBS for three 10 minute intervals. We used a donkey anti-mouse IgG secondary
antibody (molecular probes, Oregon, USA) conjugated to Alexa 488 the following day. We
incubated the ECTs with this antibody, after another washing with 1% Triton-X-100/PBS+
10% FBS+0.2% sodium azide+5% donkey serum, overnight at 4°C. Following staining with
DAPI (R37606, molecular probes, Oregon, USA) for 30 minutes at room temperature, we
incubated ECTs overnight in 100% glycerol followed by 75% glycerol for 2 hours, and then
with a clearing solution (53% benzyl alcohol, 45% glycerol, and 2% DABCO) for 2 hours.
We then changed to a new clearing solution overnight for incubation in the dark. We
stored processed samples in clearing solution at 4°C for further imaging.
We performed IF staining also on 5-µm sections. To generate these sections, after
fixation in 4% PFA for 30 minutes at room temperature, the tissues were processed to
paraffin blocks and cut to 5-µM sections, using a microtome. We blocked the sections
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with 0.1 M Glycine + 0.5% Triton X-100 in PBS. We used a primary antibody cTnT (Ms-295,
Thermo Fisher Scientific, Cambridge, US) at a ratio of 1:400, and we used a Living Colors
DsRed Polyclonal Antibody (Cat# 632495, Clontech, Takara Bio USA, Inc.) at a ratio of
1:300. We incubated sections with these antibodies in 1% BSA overnight at 4°C. The
following day, we incubated sections with Alexa Flour 488 donkey anti-mouse IgG and
Alexa Flour 594 donkey anti-rabbit IgG secondary antibodies (molecular probes, Oregon,
USA) in 5% donkey serum for 1.5 hours at room temperature. We mounted slides with
ProLong® Gold Antifade Reagent with DAPI (molecular probles, Oregon, USA).
We used a Nikon ECLIPSE Ti Confocal System (Nikon, Tokyo, Japan) attached to a
Nikon Ti-E inverted microscope platform. We captured whole mount tissue images for
alignment analyses with a 10X 0.3 NA objective at 1024 x 1024 pixel density and a 3-μm
z-interval up to 150 steps (447 μm). We captured images for cardiomyocyte-density and
ChIEF-tdT transfection efficiency with a 40x 1.30 NA objective at 1024x1024 pixel density
and 1-μm z-interval up to 5 steps, covering 2x3 fields. We captured images using Nikon
NIS Elements AR software (Nikon), and we saved the 12-bit raw files for further
processing.
Using 3D confocal stacks of whole-mount cTnT immunostained samples, we
quantified alignment of cardiomyocytes in ECT bundles. Analysis of n=9 and n=10 images
was completed for the control ECT group and the transfected paced ECT group,
respectively. The mean images size was 1.3 x 1.7 x 0.45 mm. After attenuation correction
and low pass Gaussian filtering (standard deviation of 3 µm, ImageJ, NIH, Bethesda, MD),
we merged the cTnT, tdT, and DAPI fields into a single grayscale image and manually
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segmented the whole ECT bundle with seg3D (Salt Lake City, UT). A coordinate system
was formed by extracting the centerline (medial axis) from the distance transform of the
segmented image. From the intensity gradient of the cTnT image, we calculated local
cardiomyocyte orientations and quantified alignment based on spherical statistics.
Alignment quantification was performed in Matlab (Mathworks , Natick, MA).
Real-Time Quantitative Polymerase Chain Reaction
We performed the following steps for both control and transfected paced
constructs. We cut the constructs from the collagen type-1 coated silicone membrane 6well plate (TissueTrain; Flexcell International, Hillsborough, FL). We added 2 to 4 ECT
samples into a 5 ml tube filled with 1 ml of Trizol buffer (Life Technologies, Carlsbad, CA).
We homogenized the constructs in the Trizol buffer with an Omnitip Tissue homogenizer
(Cat. No.: 6615-7273, USA Scientific, Ocala, FL) for 40 to 60 seconds at full speed on ice.
We incubated the homogenates at room temperature for 5 minutes. We added 200 µl of
chloroform (Sigma, St. Louis, MO) to the samples, we vortexed the samples, and we
incubated them at room temperature for another 5 minutes. We centrifuged samples for
20 minutes at 10,000 rpm at 4°C. After collecting the supernatant to a new tube, we added
450 µl to 550 µl of 70% ethanol. We applied 700 µl of the sample to an RNeasy mini
column (Qiagen, Valencia, CA; Cat. No.: 74104) and centrifuged the column for 15 seconds
at 10,000 rpm, discarding the flow through. We applied 700 ul of RW1 (Qiagen, Valencia,
CA; Cat. No.: 74104) onto the RNeasy column to a new 2ml collection tube, and we
centrifuged the column for 15 seconds at 10,000 rpm, discarding the flow through. We,
then, applied 500 µl of RPE buffer (Qiagen, Valencia, CA; Cat. No.: 74104) onto the
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column, and we centrifuged for 15 seconds at 10,000 rpm, discarding the flow through.
This step was repeated. We placed the column in a new 2 ml collection tube, and we
centrifuged for 1 minute at full speed to dry the column. We then transferred the column
to a new 1.5 ml RNase and DNase free tube (Qiagen, Valencia, CA; Cat. No.: 74104). We
pipetted 25 µl of RNase-free water directly onto the membrane, and we centrifuged the
tube for 1 minute at 10,000 rpm. We measured RNA concentration and purity using a
NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA). We stored RNA samples at 80ºC
We used a reverse transcription kit (Invitrogen, Carlsbad, CA; Cat. No: 11754-050).
For a single reaction, we combined the following components in a tube on ice: 4 µl of 5x
VILO Reaction Mix, 2 µl of 10x SuperScript Enzyme, ≤ 2.5 µg of RNA, and enough
diethylpyrocarbonate-treated water (DEPC-treated water) to make the total volume 20
µl. We gently mixed the contents. We incubated the tubes at 25°C for 10 mins, 42°C for
60 mins, and we terminated the reaction at 85°C for 5 minutes. We added 80 µl of DNase
free water to the sample, and we aliquoted the samples to 8 µl/tube. We stored cDNA
samples at -80°C or -20°C.
We performed quantitative polymerase chain reaction (qPCR) with a Taqman ®
Gene Expression Master Mix and an ABI 7900HT (Applied Biosystems, Foster City, CA). For
each qPCR experiment, we pooled 3 ECTs. We performed 4 qPCR experiments for both
control and paced ECTs. We added 225 µl of ddH2O to 25 µl of cDNA (250 µl) on ice. We
did this for each cDNA group used. We added 70 µl of Taqman Master mix and 7 µl of
primer to a tub on ice. We did this for each primer used. We added 11 µl of each
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Taqman/primer mixture to 3 wells of a 96-well plate (Corning Incorporated, Corning, NY)
for each analyzed group on ice. To those triplicate wells, we added 9 µl of cDNA to each
well on ice. We completed qPCR using software on the ABI 7900HT (Applied Biosystems,
Foster City, CA).
Statistical Analyses
We statistically compared D14 control (n=13) and transfected paced tissues
(n=15). We also statistically compared transfected paced ECTs (n=15) to a prolonged
culture D28 tissues (n=2). To establish a comparison between two groups, we used a ttest at a significance level of p<0.05.
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RESULTS

ChIEF transfection of h-iPSC derived cardiomyocytes within ECTs and chronic optical
pacing
Following initial pilot experiments using several AAV constructs and transfection
doses, we transfected day 14 h-iPSC derived cardiac cells with an AAV1/2-CAG-ChIEFtdTomato virus at an MOI of 500 by adding virus directly to the cell/matrix mixture at the
time of ECT formation (Figure 1A). ChIEF transfected h-iPSC-derived ECTs displayed
spontaneous beating starting around D3 of our standard 14 day in vitro culture, similar to
non-transfected control ECTs. Starting at D7 of culture, we began C-OP with a custom LED
system (Figure 1A). We recorded intrinsic beat rate, maximal OP rate, and then set C-OP
rate at greater than intrinsic but less than maximal OP rate (Figure 1B). Before initiation
of C-OP experiments, we confirmed OP depolarization and action potential generation of
cardiomyocyte within transfected ECTs using pulsed blue light stimulation and patch
clamp recording (Figure 2A).
Force testing of ChIEF h-iPSC ECTs confirm functional maturation
The following text describes force testing parameters and the definitions of these
readouts can be found in Figure S2. ChIEF-transfected ECTs were harvested at D14 and
control h-iPSC derived ECTs at D14 or D28 to quantify functional maturation. Optical
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pacing during in vitro force testing confirmed pacing capture (Figure 2B). Electrical
field pacing was used for all quantitative force-length and force-frequency data collection
and we noted rate dependent changes in both passive and active stress (Figure 2E) typical
of immature myocardium. The first indicator that C-OP increased ECT functional
maturation is the observation that C-OP ECTs displayed a higher electrical field paced MCR
than D14 control ECTs (5.37±0.69 versus 4.35±0.59 Hz, p<0.001, Figure 2C) though the
MCR for C-OP D14 ECTs was less than the MCR for D28 non-transfected ECTs (5.37±0.69
Hz versus 6.50±0.71 Hz, p<0.05, Figure 2C). Intrinsic beat rate increased in chronically
optically paced ECTS inconsistent with maturation compared with both D14 and D28, but
only significantly with D14 control constructs (1.46±0.34 Hz D14 and 1.80±0.28 Hz D28
versus 2.37±0.43 Hz TP500, p<0.01, Figure 2C). Consistent with cardiomyocyte
maturation, RT50 measured at 3.0 Hz decreased in chronically optically paced ECTs
compared to D14 controls (88.00±9.60 versus 104.23±6.66 ms, p<0.001, Figure 2D) and
further decreased by D28 (65.60±2.12 versus 88.00±9.60 ms, p<0.05, Figure 2D). The
second indicator that chronically OP increased ECT functional maturation is the
observation that chronically optically paced ECTs displayed a less negative stressfrequency relationship than D14 control ECTs, though D28 ECTs displayed a less negative
stress-frequency relationship (Figure 2E). Consistent with C-OP induced maturation in
calcium cycling, we noted reduced beat-to beat amplitude variation in active stress (σbb)
at higher frequencies in C-OP ECTs versus D14 ECTs (Figure 2F). Of note, beat-to beat
amplitude variation in active stress (σbb) was negligible by D28 (Figure 2F). Active stress
(σA) was similar between D14 and C-OP ECTs (0.72±0.39 versus 0.52±0.27 mN/mm2,
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p=0.14, Figure 2G). Active stress trended lower for D28 ECTs (0.17±0.11 versus 0.72±0.39
mN/mm2, p=0.08, Figure 2G) consistent with reduced cardiomyocyte survival following
prolonged ECT in vitro culture. Systolic energy, a normalized contractile efficiency index
calculated at 3 Hz significantly decreased in C-OP ECTs compared to D14 controls
(0.47±0.03 versus 0.54±0.02 J/m3-s, p<.001, Figure 2H). As expected, systolic energy was
lower in the more functionally mature D28 ECTs compared to C-OP ECTs (0.41±0.01 versus
0.47±0.03 J/m3-s, p<.05, Figure 2H).
Chronic optical pacing does not accelerate structural maturation
ChIEF-transfected and control h-iPSC ECTs were also harvested after D14 culture
to quantify the impact of C-OP on structural maturation. Whole h-iPSC ECTs (Figure 3A)
were placed into 2D paraffin blocks for serial section processing (Figure 3B and 3C) or
stained as whole mounts for 3D confocal imaging (Figure 3D, 3G, and 3I). ChIEF proteins
predominantly co-located with cTnT positive cells consistent with preferential
cardiomyocyte transfection (Figure 3C). Control and chronically optically paced ECTS
displayed similar cardiomyocyte percentages (50±13 vs 48±13, Figure 3E). Transfected
ECTs possessed 20±6% ChIEF-transfected cardiomyocytes (Figure 3E, inset). In contrast to
the functional maturation noted after 7 days of C-OP, cardiomyocyte alignment was
similar between control and chronically optically paced ECTs (alignment concentration (κ)
= 3.76±1.11 vs 3.42±1.33, Figure 3F). The 3D distribution and alignment of local
cardiomyocyte orientations were also similar between control (Figure 3G) and chronically
optically paced (Figure 3I) ECTs consistent with the similar active stresses noted for these
D14 h-iPSC ECT groups (Figure 2G).
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Chronic optical pacing and extended culture is associated with upregulation of mature
cardiac RNA markers
We performed RNA analysis on multiple biological replicates of D14 control and
transfected paced constructs (Figure 4). MRNA for KCNJ2, SERCA2A, and cTnT, common
markers for maturity, did not upregulate for transfected paced tissues (Figure 4). The ratio
of MLC2v and MLC2a, an indicator of ventricular phenotype development, insignificantly
increased (Figure 4A). KCND3 increased 2-fold in transfected paced constructs, suggesting
this channel partially underlies electrophysiological improvements (Figure 4B).
A single biological replicate of RT-qPCR was completed on RNA isolated from a D28
linear h-iPSC ECT (Figure 5) as has been previously completed for D28 large format h-iPSC
ECTs. Common structural and electrophysiological genes were upregulated in D28
constructs: RYR2, SERCA2A, Cacna1D, SCN4A, KCND3 (Figure 5). The types of genes
increased reflect the superior electrophysiological properties of extended ECT culture.
SERCA2A and RYR2 could underlie the superiority of D28 constructs.
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DISCUSSION

Our findings show the ChIEF AAV virus preferentially transfected h-iPSC derived
cardiomyocytes that then expressed ChIEF and enabled acute and chronic ECT OP
conditioning. Histological immunostaining of 2D paraffin sections showed co-localization
of cTnT and ChIEF expression (Figure 3C). This co-localization provides evidence that OP
directly perturbed the cardiomyocyte membrane to produce action potentials and
contractions. Furthermore, this result supports a previous report by Abilez et al. showing
efficient expression of channelrhodopsins in cardiomyocytes derived from human
induced pluripotent stem cells.47
Alignment analysis of 3D whole mount images showed OP did not affect
orientation of cells (Figure 3F). This result suggests OP does not affect pathways related
to migration like endogenous electric fields.13 In vitro electrical stimulation, unlike OP,
correlates with cellular alignment in some cases.24,29,30,32,33,34,40,41,42 However, the effect
of electrical stimulation on alignment is rather unclear. For example, some groups
observed perpendicular reorientation to the electric field; whereas, other studies
observed parallel alignment to the electric field.24,29,30,32,34,40 Radisic et al. suggested
parallel alignment underlies decreased excitation threshold because parallel alignment
optimizes use of the voltage gradient, and, in a contradictory statement, Tandon et al.
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supposed perpendicular alignment minimizes exposure to high voltage. 30,32
Furthermore, Heidi Au et al. demonstrated topographical cues influence alignment more
than electrical stimulation, and Wang et al. observed alignment only with the presence of
mechanical stimulation.28,33 Also, electrically induced alignment also seems to depend on
the initiation time of the electrical stimulation.32 For example, initiation of electrical
stimulation on day 5 failed to improve contractile apparatus organization.32 The different
cell lines used in these studies could explain the differing effects of electrical stimulation
on alignment. As mentioned before, electrical stimulation seems to be cell line
dependent.12 On the contrary, these results could suggest electrical stimulation could
possess little influence over alignment because of the inconsistent results, and the
alignment is actually the product of other cell signals such as topography. These previous
observations imply explanations for our own study.
Chronic OP ECT alignment may depend on cell line, or OP, like electrical
stimulation, could possibly have little effect on alignment compared to other signals.28,33
Also, here, we initiated C-OP on D7; C-OP may depend on time of initiation like electrical
stimulation.32 Finally, the frequencies, in this study, differed from previous ECT electrical
stimulation studies demonstrating alignment induction. Frequencies generally stayed
around 3 Hz for the full week of pacing; whereas, Nunes et al. and Hirt et al. showed most
success with a 6 Hz and 2Hz/1.5 Hz protocol, respectively.42,43
Cardiomyocyte percentage was similar between control and transfected ECTs, and
the virus transfected approximately 20% of the total cardiomyocyte population (Figure
3E). Similar cardiomyocyte percentages demonstrate the safety of AAV transfection. In
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fact, we partially chose an AAV vector because the safety of these viruses; therefore, this
result reinforced the validity of our decision to utilize this viral type.67,68 Also, the effective
transfection illustrates the feasibility of heterologous expression in these ECTs, and the
result reinforces our decision to use an AAV1. We based this decision on this serotype and
virus possessing an outstanding capacity to transfect h-iPSC-CMs.68 Finally, the number of
cardiomyocytes transfected suggest OP only requires a subset of ChIEF-expressing cells.
OP may excite a subset of cells which induce action potential propagation, through cellcell connections such as gap junctions to other cells.
Simultaneous patch clamp and OP demonstrated action potential generation in
response to light stimulation (Figure 2A). Efficient cardiomyocyte stimulation requires
action potential generation; therefore, action potential generation is important to
validate in response to OP.69 However, action potential generation must be coupled to
contraction, called excitation contraction coupling in native tissue.69 Therefore, we
showed OP could produce force-generating contractions (Figure 2B). During force testing,
OP frequencies could reach up to 5 Hz, as confirmed by pacing at this frequency. Optical
MCR was comparable to the average maximum capture electrical stimulation, 5.37 Hz.
Therefore, the limits of optical and electrical stimulation may be similar.
Chronic OP was successfully performed for seven days (Figure 1B). Successful COP supports the decision to use ChIEF, and this success further demonstrates the validity
of using an AAV vector. We chose ChIEF because the channel does not desensitize with
chronic light stimulation, and, partially, we chose an AAV because of the vector’s
persistent transgene expression.52,68 Because of the success of C-OP, these two properties

40

proved to be useful in C-OP. Success shows the light channel did not desensitize and
remained stably expressed throughout the seven-day period. Also, successful chronic
pacing demonstrates the utility our custom-built LED system loosely based on the LED
model system developed by Abilez.59
Chronic OP significantly increased both MCR and intrinsic beat rate from D14
controls (Figure 2C). However, MCR of extended D28 ECTs was significantly higher than
transfected paced constructs. MCR is an indicator of improvement in electrical properties
because a higher MCR coincides with increased connexin43 expression and potassium
channel expression.43,70 MCR increased previously due to extended culture, providing a
basis for the result of extended culture in the present study, and further associating
extended culture with maturation.70 The result of C-OP is similar to chronic electrical
pacing studies, demonstrating MCR improvements.10,38,43 Most importantly, this
improvement in MCR was comparable to a previous ECT chronic electrical stimulation
study. Nunes et al. showed chronic electrical stimulation increased MCR by approximately
1 Hz.43 We show C-OP also increased MCR of ECTs by approximately 1 Hz. However, we
improved MCR without invading the tissue, and we did not immobilize the tissue,
maintaining differentiation by mechanical stretch unlike Nunes.11,43
With regard to the change in intrinsic beat rate, C-OP did not induce a decrease in
spontaneous beating indicative of maturation (Figure 2C).9 Our result differed with a
previous study concerning electrical stimulation of human induced pluripotent stem cell
derived cardiac spheroids. That study, by Richards et. al, showed a decrease in
spontaneous beating rate, possibly resulting from a decrease HCN4, a pacemaking
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channel.35 However, our result agreed with a study that used electrical stimulation of
mouse derived cardiac EBs.36 This study, by Ahadian et al., demonstrated electrical pacing
increased spontaneous beating rate.36 Possibly, electrical stimulation affects intrinsic beat
rate of various cell types differently, and the same result exists with chronic light pacing.
OP may induce a consistent upregulation in HCN4 channels unlike normal
electrophysiological maturation.
Along with an improvement in MCR, C-OP significantly decreased beat-to-beat
variation at all frequencies and relaxation time compared to D14 controls (Figure 2D, 2F).
Similar to MCR, D28 constructs possessed lower beat-to-beat variation and significantly
different relaxation time than transfected paced constructs. This result was consistent
with a previous study associating extended ECT culture with improved relaxation time.70
Like MCR, improved hysteresis and relaxation time correlate with increased connexin43
expression and upregulation of potassium channel expression.70 Godier-Furnemont et al.
also showed an improvement in relaxation time due to electrical stimulation of ECT
constructs similar to OP.44 Mathematical modeling demonstrates hysteresis occurs due
to out-of-phase action potentials and calcium cycling.71 Thus, we also propose the
decreased hysteresis indicates maturation of excitation-contraction coupling.
Chronic OP ECTs maintained active stress, as a function of increasing pacing
frequency, better than D14 control constructs (Figure 2E). D28 constructs maintained
active stress better than transfected paced constructs at most frequencies, but D28
constructs were only significantly different at 4.5 Hz and 5 Hz. These results further
associate extended ECT culture with maturation as observed in a previous study.70 Better
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maintenance of active stress allows coupling to higher pacing rates in vivo without
sacrificing force production.8 The underlying mechanism for improved maintenance of
active stress production correlates with increased expression and development of
calcium handling structures.44 Calcium handling stores and proteins allow improved stress
preservation because these proteins cause quicker release and reuptake of calcium, the
ion involved in force production.44 However, unlike Godier-Furnemont et al. electrical
stimulation study, C-OP did not generate a positive force frequency relationship.44
Moreover, C-OP did not induce a positive-force frequency relationship as seen in D28
constructs in a previous study.70
We did note that absolute active stress trended lower in chronically OP constructs
compared to D14 controls but higher than D28 constructs (Figure 2G). Despite increased
functional maturation defined by ECT electrical properties, active stress trended
downward with extended culture, perhaps due to limited nutrient diffusion or cell death10
Possibly, optogenetic stimulation, ChIEF expression, or AAV transfection decreased active
stress through some toxicity. Optogenetic stimulation may generate hydrodynamic shear,
a morphology-altering force.10 This result is in contrast to chronic electrical stimulation.
Chronic electrical stimulation of ECT constructs increased active force by 1.5 times.42
However, our result may differ due to differences in the stimulation protocols. For
example, chronic electrical stimulation involved pacing at 2Hz/1.5Hz; whereas, our
protocol usually paced tissues at around 3 Hz.42 Lower pacing rates may be more
conducive to stimulating sarcomere maturation and increased active stress. Possibly,
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survival in ECT is cell-line dependent and another cell line would possess improved
survival after C-OP or extended culture.
Transfected paced constructs used significantly less systolic energy during
contraction at 3 Hz pacing compared to D14 control constructs (Figure 2H). However, D28
constructs used significantly less systolic energy than transfected paced constructs
(Figure 2H). Systolic energy use was significantly different as indicated by decreased
stress-time integral values. The stress-time integral relates to energy consumption during
contraction.72 Increased expression of mitochondrial genes and mitochondria number
could underlie this result as observed in electrical pacing of neonatal rat
cardiomyocytes.18 Possibly, CPT-1 expression could be transitioning to the muscle isoform
of the CPT-1 enzyme.18
RT-qPCR analysis suggests KCND3, the gene encoding the Kv4.3 channel, the
channel responsible for the transient outward Ito, at least partially underlies the
electrophysiological maturation induced by C-OP (Figure 4B).70,73 This channel provides a
partial mechanism for electrophysiological maturation as the mRNA was the only gene
significantly upregulated gene in transfected paced constructs (Figure 4B). KCND3
increases with extended culture, signifying its role in maturity.70 Furthermore, increased
expression of Kv4.3 could improve hysteresis and MCR because the channel decreases
repolarization time; overexpression of Kv4.3 in isolated guinea pig myocytes decreased
membrane potential during the plateau phase and shortened action potential duration.74
Surprisingly, RNA analysis did not reveal significant upregulation of calcium ion channels
or SERCA2A to explain active stress preservation (Figure 4A). Possibly, Western blot
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analysis would reveal differences at the protein level, or the degree of protein
phosphorylation and activation, as observed previously with electrical pacing.44 This RNA
result was consistent with a previous ECT electrical stimulation study that showed no
upregulation of SERCA2A.42 The one biological replicate of D28 control constructs
suggests far greater expression of mature cardiac proteins in comparison with transfected
paced constructs (Figure 5). D28 constructs possessed greater expression of the following
mRNA compared to transfected paced constructs: MLC2v/MLC2a, RYR2, SERCA2,
Cacna1D, SCN4A, and KCND3. The larger number of increased mRNA, especially RYR2 and
SERCA2, could underlie the significantly improved electrophysiological characteristics of
D28 constructs (Figure 5A).
As stated previously, ECTs possess an immature phenotype, limiting their clinical
translation as a cardiovascular regeneration therapy or viable drug testing platform.9,57
Bioreactors that mimic the in vivo environment induce differentiation and maturation. 10
The in vivo signals replicated include mechanical stretch, perfusion, and electrical
stimulation.9 However, no ECT differentiates into a fully mature construct.9 Also, electrical
stimulation can be invasive, produces toxic Faradaic reactions, and has low
spatiotemporal resolution.43,45,46,47,48 Because ECTs still retain immaturity and chronic
electrical stimulation has hindrances, the cardiac tissue engineering field needs
alternative, less toxic, conditioning protocols that produce a level of maturity comparable
to electrical stimulation. We present here a novel, alternative, chronic, less toxic, action
potential inducing, stimulation protocol for cardiac tissue engineering, using expression
of light sensitive ion channels. After extensive review, this is the first successful attempt
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at C-OP of engineered ECTs consisting of h-iPSC cardiac cells. Furthermore, we provide
evidence for the possibility of functional maturation, utilizing this technique. Also, the
light stimulation protocol developed is economically feasible, only requiring easily
obtainable components, and the Arduino hardware and IDE is user-friendly.
The results of our current study may have alternate interpretations.

The

electrophysiological maturation observed could be due to indirect effects of C-OP. For
example, light stimulation, by indirectly causing increased mechanical stretch or
perfusion, could induce electrophysiological maturity.9,10 Possibly, C-OP causes secretion
of growth factors, such as VEGF and bFGF, into the supernatant similar to previous
electrical stimulation studies.22,25 Furthermore, our cell population consists of a mixture
of cardiomyocytes, endothelial cells, and mural cells. We could not control the ratios
between these cell types because differentiation produces a different mixture of cells for
every experiment. We used the same hIPS cell stock for each differentiation protocol;
however, many ECTs were made from a different differentiated cell lot. A different cell
population for every experiment may influence results because a previous study, by our
lab, shows ratio of cell types influences electrophysiological properties.8 Presence of
certain cells can activate pathways related to tissue maturation.8 Also, stem cell derived
cardiomyocytes co-cultured with endothelial cells beat more synchronously, suggesting
cell population variability could have an effect on efficacy of C-OP.75
Limitations also exist in the present study. AAV transfection or ChIEF expression
may generate an immune rejection after ECT implantation; however, primate brains
express channelrhodopsins for long periods of time with persistence and lack of toxic side
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effects, suggesting long-term in vivo implantation may be possible.51 Furthermore, we do
not know whether we used the most efficient virus or channelrhodopsin variant. Also, we
did not fully optimize the viral dose; a smaller viral dose used could reduce toxicity and
improve transfection efficiency. Also, we did not account for transfected endothelial cells
and mural cells which could affect dose. Channelrhodopsins can express in vascular
endothelial cells, and these endothelial cell populations can respond to light with shifts in
membrane potential.76 Therefore, transfected EC cells could have an effect on maturity
induced by C-OP. Further optimization of the light pacing protocol could improve ECT
maturity, and optimization could improve active stress measurements. For example, the
length of C-OP and the time of initiation for C-OP requires optimization. The length,
frequency, and pulse width for pacing was arbitrarily chosen based on successful OP
capture. Experimental groups in the study could be improved. The number of d28 groups
was small compared to other groups, and we did not use a group to directly assess the
toxicity of the light itself. Furthermore, an underlying mechanism for the functional data
requires further explanation.
To improve these limitations, a comparison between different variants of
channelrhodopsins and viruses could elucidate the most appropriate channelrhodopsin
and virus for chronic optogenetic excitation. For example, CatCh, a channelrhodopsin
preferential to calcium entry, could be more appropriate for maturation of engineered
cardiac tissue because calcium cycling induces hypertrophy in cardiac cells.15,54 Patch
clamp could assess kinetics of different channelrhodopsin variants in this cell line to
improve comparison of the variants. Also, a complementary study, similar to Tandon et
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al.’s study regarding electrical stimulation, focusing on viral dose and parameters of the
conditioning protocol, such as pacing frequency, would be helpful.38 An improved viral
dose could increase transfection efficiency; a higher transfection efficiency could improve
pacing to ensure stimulation of the whole construct similar to complete field stimulation
observed in electrical stimulation protocols. Possibly, complete stimulation of the whole
construct simultaneously could improve construct maturity. However, greater
transfection efficiency would require a balance with toxicity. Chronic optical pacing to d28
may increase C-OP construct maturity above non-paced d28 construct. C-OP to d28 may
overcome the paradox of extended culture’s association with both maturity and massive
cell loss. Also, to account for transfected endothelial cells and mural cells that might affect
dose, we could stain for endothelial cells and mural cells, using an antibody for these cell
types. Also, optimization of light intensity needed for optical excitation could reduce
thermal effects and phototoxicity.51 In a future study, we could add a control group that
undergoes light stimulation to directly assess the toxicity of our light system. With
reduced toxicity, active stress of chronically optically stimulated constructs may improve.
Furthermore, a cell viability assay would be beneficial to directly assess toxicity such as
an MTT assay. We could assess toxicity of the virus itself by transfection of ECTs with a
null, unpackaged, AAV virus. We could increase the number of d28 groups to further
establish this group as a more mature experimental group. Finally, a more comprehensive
gene and protein analysis could elucidate mechanistic insights of C-OP. This analysis could
include protein phosphorylation studies to further define cell signaling pathways affected
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by C-OP. Further patch clamp studies could define the effect ChIEF activation has on other
ion exchange channels at the CM membrane.
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SUMMARY AND CONCLUSIONS

The immature phenotype of ECTs may limit their therapeutic translation. Chronic
conditioning protocols, such as, mechanical stretch, perfusion, and electrical stimulation
induce tissue maturation. However, electrical stimulation can be invasive, produces toxic
Faradaic byproducts, and has low spatiotemporal resolution. As an alternative, less
invasive, less toxic, more precise method of chronic stimulation, we used optical
excitation of heterologously expressed ChIEF light-sensitive ion channels.
Using an AAV packaged with a ChIEF, we successfully expressed light-sensitive ion
channels in ECTs composed of human induced pluripotent derived cardiac cells. We
successfully paced these constructs for 7 days, and this chronic stimulation induced
electrophysiological maturation: improvements in MCR, hysteresis, KCND3 expression,
and force-frequency relationships.
The research completed provides a novel chronic conditioning method, and, this
conditioning method could possibly induce maturity in engineered cardiac tissues before
regenerative treatments or drug testing. Further research in optogenetic applications to
cardiac tissue engineering could improve this conditioning protocol to demonstrate
improved efficacy compared to current non-optical conditioning protocols.
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Figure 1. ECT formation and chronic optical pacing protocol. (A) ECTs were generated
from a multi-component mixture of cardiomyocytes, endothelial cells, and mural cells,
differentiated from h-iPSCs. Cells were mixed with culture medium, collagen I, and
Matrigel. AAV1/2-CAG-oChIEF-tdTomato virus was then added to the gel mixture at 500
MOI. The gel mixture was poured into FlexCell TissueTrain wells deformed into a
cylindrical mold by vacuum suction and anchored by nylon mesh tabs. The TissueTrain
plate was placed on top of an Arduino-controlled LED platform for chronic optical pacing.
ECTs were cultured at 37C, 5% CO2. (B) At culture day 7, chronic optical stimulation was
initiated using a pulsed 470 nm LED. A representative chronic optical stimulation protocol
is shown. At each culture day, we measured the maximum capture rate and set the
chronic optical stimulation rate 0.5 Hz below the maximal capture rate.
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Figure 2. Impact of chronic optical pacing (C-OP) on functional maturation of h-iPSC
ECTs. (A) Representative patch clamp recording from a D14 h-iPSC-CM after ECT ChIEF
transfection. Blue ticks indicate 470 nm light pulses. (B) Representative stress trace during
acute optical pacing of a C-OP ECT. After 3 seconds of spontaneous beating, we began
acute pacing with a 470 nm 3.5 Hz pulsed LED. (C) Mean intrinsic beat rate and maximal
capture rate (MCR) for D14 control (n=13), D14 C-OP (n=15) and D28 (n=2) ECTs. Intrinsic
beat rate increased after C-OP and MCR increased after C-OP and prolonged culture to
D28. (D) Mean RT50 AT 3 Hz acute electrical pacing decreased after C-OP and after
prolonged culture to D28. (E) Stress-frequency curves showed a less negative relationship
after C-OP or prolonged culture to D28. (F) Pacing rate dependent beat-to-beat hysteresis
decreased after C-OP and was absent in D28 ECTs. (G) Mean active stress was similar in
D14 control and C-OP ECTs and trended lower in D28 ECTs (p=0.08 vs. D14 control). (H)
Mean normalized systolic energy at 3 Hz acute electrical pacing decreased after C-OP and
further decreased by D28. Error bars show standard deviations. See (C) for color legend.
Results in (C-H) obtained with 5 V acute electrical field pacing. * p<0.05, ** p<0.001 vs.
D14 control, † p<0.05 vs. D28.
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Figure 3. Impact of chronic optical pacing (C-OP) on structural maturation of h-iPSC ECTs.
(A) Representative, linear and cylindrical h-iPSC ECT constrained at the long axis ends by
mesh nylon anchors. (B-C) Representative central paraffin sections of a (B) D14 control
ECT showing 54% cardiomyocytes (CM) and (C) D14 C-OP ECT showing 52% CM and 13%
ChIEF-transfected cells. Nuclei were stained with DAPI (blue), CM with cTnT (green) and
ChIEF-transfected cells with tdT (red). CM were predominantly located at the outer
surface and the majority of transfected cells were CM. Inset in (C) shows higher
magnification of double-positive cTnT and tdT cells. (D) Whole mount confocal image of
a control D14 ECT. (E) Mean CM fraction showing mean CM transfection rate (inset).
Mean CM fraction and (F) Mean alignment concentration (κ) were similar in D14 control
(n=9) and C-OP (n=10) h-iPSC ECTs. Error bars show standard deviations. (G-J)
Representative local CM orientations within D14 (G) control and (I) C-OP h-iPSC ECTs.
Color-coded lines indicate local CM orientation magnitudes in the circumferential (green),
radial (red), and axial (blue) directions. For clarity, only a subset of the orientations is
shown. Insets are 3X magnification of regions enclosed by the yellow dashed lines. (H and
J) Spherical histograms of local CM orientations. CM in both control and C-OP aligned
parallel to the ECT long axis. The volume of each ray represents the relative count in each
direction and the mean CM orientation is shown by the thick red line. κ for the control
sample (H) was 3.89 while the C-OP sample (J) was 3.46. Scale bars: 5 mm (A), 250 μm (B,
C, D, G, I), 100 μm (C inset). Orientation axes also serve as scale bars in (D, G, I).
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Figure 4. Quantitative PCR of genes encoding contractile proteins, Ca2+ cycling
mechanisms, and ion channels in D14 control and C-OP ECTs. (A) Expression of genes
related to cardiomyocyte contraction (cTnT, ventricular myosin light chain 2 [MLC2v],
atrial MLC2 [MLC2a], and MLC2v/MLC2a ratio) and genes related to Ca 2+ transients
(ryanodine receptor 2 [RYR2], ATPase sarcoplasmic/endoplasmic reticulum Ca 2+
transporting 2 [SERCA2], phospholamban [PLN], calsequestrin 2 [CASQ2], aspartate betahydroxylase [ASPH], and sodium/calcium exchanger 1 [SLC8A1]). C-OP did not produce
significant differences in expression of contractile- or Ca2+-transient- related genes. (B)
Expression of genes encoding sarcolemmal voltage-gated ion channels L-type Ca2+
(Cacna1C, Cacna1D), T-type Ca2+ (Cacna1G), Na+ (SCN4A, SCN5A), and K+ (KCNH2 [rapidly
activating delayed rectifying], KCNJ2, KCNJ12 [inward rectifying], KCND3 [transient
outward]) and connexin (GJA1). C-OP resulted in a significant increase in the expression
of transient outward K+ channel KCND3. Expression of all other ion channels and connexin
were unchanged after C-OP. * p<0.05. For each gene, 2-4 biological experiments were
conducted and qPCR was performed in triplicate for each biological sample. Error bars
show standard deviations.
54

Figure 5. Quantitative PCR for a single biological experiment comparing D14 control,
D14 C-OP, and D28 ECTs. (A) Expression of genes related to cardiomyocyte contraction
(cTnT, ventricular myosin light chain 2 [MLC2v], atrial MLC2 [MLC2a], and MLC2v/MLC2a
ratio) and genes related to Ca2+ transients (ryanodine receptor 2 [RYR2], ATPase
sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [SERCA2], phospholamban
[PLN], and calsequestrin 2 [CASQ2]). Expression was similar for all genes in D14 control
and C-OP, following the full qPCR study in Figure 3. The MLC2v/MLC2a was increased in
the D28 sample, suggesting a more ventricular phenotype, while increased RYR2 and
SERCA2 and decreased PLN suggest more mature Ca2+ handling. (B) Expression of genes
encoding sarcolemmal voltage-gated ion channels L-type Ca2+ (Cacna1C, Cacna1D), T-type
Ca2+ (Cacna1G), Na+ (SCN4A, SCN5A), and K+ (KCNJ2 [inward rectifying], KCND3 [transient
outward]) and connexin (GJA1). The expression of transient outward K + channel KCND3
was increased in both the C-OP and D28 samples, suggesting a role for this channel in
electrophysiological maturation during C-OP. L-type Ca2+ and Na+ were also increased in
the D28 sample, but did not show a similar increase in C-OP ECTs.
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Figure S1. Analysis of ECT function. For this representative C-OP ECT at 4.5 Hz acute
electrical pacing, mean σA was 0.29 mN/mm2, σbb was 0.17, RT50 was 63 ms, and
normalized systolic energy was 0.53. (A) Representative stress vs. time data. Force data
was divided by ECT cross-sectional area to calculate stress. A cycle is defined as
contraction followed by relaxation. The minimum stress before the onset of contraction
is σmin and the peak stress is σmax. Active stress, σA, is the difference between σmax and
σmin. Beat-to-beat hysteresis, σbb, is the magnitude of the difference between the σA of an
even-numbered cycle and the σA of the preceding odd-numbered cycle, divided by the
overall mean σA. (B) Fast Fourier transform (FFT) analysis of the stress vs. time signal. An
acute electrical pacing frequency was considered captured if it matched the peak
frequency of the FFT power spectrum. (C) RT50 calculated for cycle 1 in (A). RT50 is the
time for stress to relax by 50% of σA from σmax. (D) Normalized systolic energy calculated
for cycle 1 in (A). Stress and cycle time were both normalized to a maximum value of 1.
The area of the shaded region under the stress-time curve is related to systolic energy
during contraction.
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Figure S2. Representative force tracings at increasing pacing rates display decreasing
active force and increasing beat-to-beat hysteresis. Note that there is a decrease in
active force and increase in passive force with each increase in pacing frequency,
consistent with the limited capacity for immature cardiac tissues to release and
recapture calcium at higher pacing rates. Also note that there is a progressive increase
in the beat to beat amplitude variation of active and passive force with each increase in
pacing frequency, consistent with increased hysteresis.
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DEPARTMENT OF
ENVIRONMENTAL HEALTH
AND SAFETY

University of Louisville
1800 Arthur St
Louisville KY 40208-2729

March 07, 2016
RE: IBC Registration #IBC 16-105: New human iPSC-derived cardiomyocytes for cardiac repair
Effective 03/07/2016; Expires 03/06/2021
Dear Dr. Keller,
The above registration was reviewed and approved by the Institutional Biosafety Committee.
Institutional Biosafety Committee approval is granted for a period of five (5) years. During the approval
period, it is the responsibility of the Principal Investigator to notify the IBC of any changes (via
Modification Request in iRIS):

•
•
•
•

Addition of Risk Group 2 and above agents
Addition of Personnel working on the protocol
Change of location of research facilities
Significant modification of methods, specifically to include aerosol generating equipment (e.g.
cell counter)

A new application must be submitted before the end of the five-year period as outlined in the IBC
Application/Registration Instructions that can be found on the DEHS web site at
https://louisville.edu/dehs/biosafety/institutional-biosafety-committee-ibc.html.
It is the responsibility of the Principal Investigator to ensure that all individuals performing activities under
this protocol maintain required training certifications for the duration of the approval period. Specifically,
if you are working with human or primate source materials, annual bloodborne pathogen training is
required. Biosafety, Bloodborne Pathogens and other online training courses are offered through the
Department of Environmental Health and Safety (via Bioraft at:
https://louisville.bioraft.com). Any agent / organism / lab specific training must be provided by the
Principal Investigator or designee.
If you have any questions, please contact the Biosafety Program, or myself, in the Department of
Environmental Health and Safety at 852- 6670.
Sincerely,

Torsten A. Hopp, Ph.D.
Biosafety Officer
Department of Environmental Health and Safety
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